creatine has been researched along with Basal Ganglia Diseases in 8 studies
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There are several reports of MRS in Parkinson's disease(PD) and multiple system atrophy(MSA)." | 2.40 | [Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy]. ( Aotsuka, A; Hattori, T; Shinotoh, H, 1997) |
| "This elevation is unrelated to hepatic encephalopathy or a history of intravenous drug abuse, and suggests that a biological process underlies the extrahepatic symptoms in chronic HCV infection." | 1.31 | Evidence for a cerebral effect of the hepatitis C virus. ( Allsop, JM; Forton, DM; Foster, GR; Main, J; Taylor-Robinson, SD; Thomas, HC, 2001) |
| " Creatine substitution by means of oral creatine monohydrate at high dosage (4-8 g per day) resulted in a striking improvement of the extrapyramidal movement disorder, normalisation of abnormal slow background activity in the EEG, and disappearance of bilateral abnormal signal intensities in the globus pallidus." | 1.30 | Guanidinoacetate methyltransferase deficiency: a newly recognized inborn error of creatine biosynthesis. ( Hanefeld, F; Stöckler, S, 1997) |
| "Myoinositol was elevated in the patient with abnormally high serum sodium, and decreased in the hemolytic-uremic syndrome." | 1.30 | 1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis. ( Berry, GT; Bilaniuk, LT; Gibson, J; Haselgrove, JC; Hunter, JV; Kaplan, BS; Kaplan, P; Lam, WW; Wang, ZJ; Zhao, H; Zimmermann, RA, 1998) |
| "Oral creatine replacement has proved to be effective in one child with an inborn error of GAMT." | 1.29 | Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. ( Frahm, J; Hanefeld, F; Stöckler, S, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamasue, H | 1 |
| Fukui, T | 1 |
| Fukuda, R | 1 |
| Kasai, K | 1 |
| Iwanami, A | 1 |
| Kato, N | 1 |
| Kato, T | 1 |
| Kin, T | 1 |
| Hirano, M | 1 |
| Taoka, T | 1 |
| Takamure, M | 1 |
| Furiya, Y | 1 |
| Kichikawa, K | 1 |
| Ueno, S | 1 |
| Fujimoto, T | 1 |
| Nakano, T | 1 |
| Takano, T | 1 |
| Takeuchi, K | 1 |
| Yamada, K | 1 |
| Fukuzako, T | 1 |
| Akimoto, H | 1 |
| Stöckler, S | 2 |
| Hanefeld, F | 2 |
| Frahm, J | 1 |
| Aotsuka, A | 1 |
| Shinotoh, H | 1 |
| Hattori, T | 1 |
| Lam, WW | 1 |
| Wang, ZJ | 1 |
| Zhao, H | 1 |
| Berry, GT | 1 |
| Kaplan, P | 1 |
| Gibson, J | 1 |
| Kaplan, BS | 1 |
| Bilaniuk, LT | 1 |
| Hunter, JV | 1 |
| Haselgrove, JC | 1 |
| Zimmermann, RA | 1 |
| Forton, DM | 1 |
| Allsop, JM | 1 |
| Main, J | 1 |
| Foster, GR | 1 |
| Thomas, HC | 1 |
| Taylor-Robinson, SD | 1 |
1 review available for creatine and Basal Ganglia Diseases
| Article | Year |
|---|---|
[Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].
Topics: Aspartic Acid; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Brain; Choline; Creatine; | 1997 |
7 other studies available for creatine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia Diseases; Choline; Chronic Disease; Creati | 2003 |
Proton MR spectroscopy of adult-onset dentatorubral-pallidoluysian atrophy.
Topics: Aged; Aspartic Acid; Atrophy; Basal Ganglia Diseases; Case-Control Studies; Choline; Creatine; Denta | 2005 |
Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.
Topics: Adult; Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Brain Mapping; Choline; Chronic Disease | 1996 |
Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism.
Topics: Basal Ganglia Diseases; Brain; Creatine; Developmental Disabilities; Guanidinoacetate N-Methyltransf | 1996 |
Guanidinoacetate methyltransferase deficiency: a newly recognized inborn error of creatine biosynthesis.
Topics: Amino Acid Metabolism, Inborn Errors; Basal Ganglia Diseases; Creatine; Creatinine; Guanidinoacetate | 1997 |
1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis.
Topics: Adolescent; Adult; Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases, Metabolic; | 1998 |
Evidence for a cerebral effect of the hepatitis C virus.
Topics: Adult; Basal Ganglia; Basal Ganglia Diseases; Biopsy; Brain; Brain Diseases; Choline; Creatine; Fati | 2001 |